Tags

Type your tag names separated by a space and hit enter

Chloroquine and hydroxychloroquine in covid-19.
BMJ. 2020 04 08; 369:m1432.BMJ

Links

Publisher Full Text
Aggregator Full Text

Authors+Show Affiliations

Ferner RE
Institute of Clinical Sciences, University of Birmingham, Birmingham, UK r.e.ferner@bham.ac.uk.
Aronson JK
Centre for Evidence-Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

MeSH

Antiviral AgentsBetacoronavirusCOVID-19ChloroquineClinical Trials as TopicCoronavirus InfectionsDrug Evaluation, PreclinicalEndpoint DeterminationHumansHydroxychloroquinePandemicsPneumonia, ViralResearch DesignSARS-CoV-2

Pub Type(s)

Editorial

Language

eng

PubMed ID

32269046

Clinical Trial Links

Baricitinib Therapy in COVID-19

Citation

Ferner, Robin E., and Jeffrey K. Aronson. "Chloroquine and Hydroxychloroquine in Covid-19." BMJ (Clinical Research Ed.), vol. 369, 2020, pp. m1432.
Ferner RE, Aronson JK. Chloroquine and hydroxychloroquine in covid-19. BMJ. 2020;369:m1432.
Ferner, R. E., & Aronson, J. K. (2020). Chloroquine and hydroxychloroquine in covid-19. BMJ (Clinical Research Ed.), 369, m1432. https://doi.org/10.1136/bmj.m1432
Ferner RE, Aronson JK. Chloroquine and Hydroxychloroquine in Covid-19. BMJ. 2020 04 8;369:m1432. PubMed PMID: 32269046.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Chloroquine and hydroxychloroquine in covid-19. AU - Ferner,Robin E, AU - Aronson,Jeffrey K, Y1 - 2020/04/08/ PY - 2020/4/10/entrez PY - 2020/4/10/pubmed PY - 2020/4/14/medline SP - m1432 EP - m1432 JF - BMJ (Clinical research ed.) JO - BMJ VL - 369 SN - 1756-1833 UR - https://www.unboundmedicine.com/medline/citation/32269046/Chloroquine_and_hydroxychloroquine_in_covid_19_ L2 - https://www.bmj.com/lookup/pmidlookup?view=long&pmid=32269046 DB - PRIME DP - Unbound Medicine ER -